Hemispherian As reported raising $57,700 in an initial SEC Form D filing, from an offering of $57,700
Amount Raised
$57,700
Round Type
Pre-Seed
NorwayHealthcareQuick answer
Hemispherian AS raised $57,700 in a Pre-Seed round, dated January 4, 2021. Hemispherian AS is based in Norway.
- How much did Hemispherian AS raise?
- Hemispherian AS raised $57,700 in a Pre-Seed round on January 4, 2021.
- What does Hemispherian AS do?
- Hemispherian is a biotechnology firm that formulates new treatments for all kinds of cancer.
- Where is Hemispherian AS based and how big is it?
- Hemispherian AS is based in Norway.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Hemispherian AS that raised within 45 days of this round, from Fundz verified event records.
- MISSION AUTISM CLINICS raised $2.8M (Seed) on February 18, 2021.
- Pneuma Respiratory raised $438K on February 18, 2021.
- Q'Apel Medical raised $22M on February 18, 2021.
- Flyte raised $240K (Seed) on February 18, 2021.
- Pneuma Respiratory raised $430K on February 18, 2021.
- ImmunoRx Pharma, Inc. raised $2.7M (Seed) on February 17, 2021.
Who to call at Hemispherian AS, and when
A new round usually means Hemispherian AS is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Hemispherian AS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hemispherian AS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hemispherian AS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hemispherian AS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Hemispherian AS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.